<VariationArchive RecordType="classified" VariationID="1328976" VariationName="NM_018082.6(POLR3B):c.1763del (p.Asp588fs)" VariationType="Deletion" Accession="VCV001328976" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2021-12-25" MostRecentSubmission="2021-12-25">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1319663" VariationID="1328976">
      <GeneList>
        <Gene Symbol="POLR3B" FullName="RNA polymerase III subunit B" GeneID="55703" HGNC_ID="HGNC:30348" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="106357748" stop="106510198" display_start="106357748" display_stop="106510198" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="106751435" stop="106903975" display_start="106751435" display_stop="106903975" Strand="+" />
          </Location>
          <OMIM>614366</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_018082.6(POLR3B):c.1763del (p.Asp588fs)</Name>
      <CanonicalSPDI>NC_000012.12:106433853:A:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12q23.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="106433854" stop="106433854" display_start="106433854" display_stop="106433854" variantLength="1" positionVCF="106433853" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="106827632" stop="106827632" display_start="106827632" display_stop="106827632" variantLength="1" positionVCF="106827631" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>D530fs</ProteinChange>
      <ProteinChange>D588fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.106827632del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.106827632del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.106433854del" Assembly="GRCh38">
            <Expression>NC_000012.12:g.106433854del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_031837.1" sequenceAccession="NG_031837" sequenceVersion="1" change="g.81197del">
            <Expression>NG_031837.1:g.81197del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001160708.2" sequenceAccession="NM_001160708" sequenceVersion="2" change="c.1589del">
            <Expression>NM_001160708.2:c.1589del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001154180.1" sequenceAccession="NP_001154180" sequenceVersion="1" change="p.Asp530fs">
            <Expression>NP_001154180.1:p.Asp530fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_018082.6" sequenceAccession="NM_018082" sequenceVersion="6" change="c.1763del" MANESelect="true">
            <Expression>NM_018082.6:c.1763del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_060552.4" sequenceAccession="NP_060552" sequenceVersion="4" change="p.Asp588fs">
            <Expression>NP_060552.4:p.Asp588fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2137005362" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_018082.6(POLR3B):c.1763del (p.Asp588fs) AND Hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism" Accession="RCV001797867" Version="2">
        <ClassifiedConditionList TraitSetID="7653">
          <ClassifiedCondition DB="MedGen" ID="C3280644">Hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-12-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-12-23" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-12-25" MostRecentSubmission="2021-12-25">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="7653" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16699" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hypomyelinating leukodystrophy 8, with or without oligodontia and/or hypogonadotropic hypogonadism</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH HYPODONTIA AND HYPOGONADOTROPIC HYPOGONADISM</ElementValue>
                <XRef Type="Allelic variant" ID="614366.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614366.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614366.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="614366.0007" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebellar hypoplasia with endosteal sclerosis</ElementValue>
                <XRef ID="Cerebellar+Hypoplasia+with+Endosteal+Sclerosis/1213" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Endosteal sclerosis-cerebellar hypoplasia syndrome</ElementValue>
                <XRef ID="MONDO:0008940" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism</ElementValue>
                <XRef ID="MONDO:0013722" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HLD8</ElementValue>
                <XRef Type="MIM" ID="614381" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">POLR3-related leukodystrophy, a hypomyelinating leukodystrophy with specific features on brain MRI, is characterized by varying combinations of four major clinical findings: Neurologic dysfunction, typically predominated by motor dysfunction (progressive cerebellar dysfunction, and to a lesser extent extrapyramidal [i.e., dystonia], pyramidal [i.e., spasticity] and cognitive dysfunctions). Abnormal dentition (delayed dentition, hypodontia, oligodontia, and abnormally placed or shaped teeth). Endocrine abnormalities such as short stature (in ~50% of individuals) with or without growth hormone deficiency, and more commonly, hypogonadotropic hypogonadism manifesting as delayed, arrested, or absent puberty. Ocular abnormality in the form of myopia, typically progressing over several years and becoming severe. POLR3-related leukodystrophy and 4H leukodystrophy are the two recognized terms for five previously described overlapping clinical phenotypes (initially described as distinct entities before their molecular basis was known). These include: Hypomyelination, hypodontia, hypogonadotropic hypogonadism (4H syndrome); Ataxia, delayed dentition, and hypomyelination (ADDH); Tremor-ataxia with central hypomyelination (TACH); Leukodystrophy with oligodontia (LO); Hypomyelination with cerebellar atrophy and hypoplasia of the corpus callosum (HCAHC). Age of onset is typically in early childhood but later-onset cases have also been reported. An infant with Wiedemann-Rautenstrauch syndrome (neonatal progeroid syndrome) was recently reported to have pathogenic variants in POLR3A on exome sequencing. Confirmation of this as a very severe form of POLR3-related leukodystrophy awaits replication in other individuals with a clinical diagnosis of Wiedemann-Rautenstrauch syndrome.</Attribute>
                <XRef ID="NBK99167" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1195" />
                <XRef ID="1195" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301509</ID>
                <ID Source="BookShelf">NBK1334</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22855961</ID>
                <ID Source="BookShelf">NBK99167</ID>
              </Citation>
              <XRef ID="85186" DB="Orphanet" />
              <XRef ID="88637" DB="Orphanet" />
              <XRef ID="C3280644" DB="MedGen" />
              <XRef ID="MONDO:0013722" DB="MONDO" />
              <XRef Type="MIM" ID="614381" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4004859" SubmissionDate="2021-12-23" DateLastUpdated="2021-12-25" DateCreated="2021-12-25">
        <ClinVarSubmissionID localKey="SUB10843957" submittedAssembly="GRCh38" title="SUB10843957" />
        <ClinVarAccession Accession="SCV002039192" DateUpdated="2021-12-25" DateCreated="2021-12-25" Type="SCV" Version="1" SubmitterName="Institute for Human Genetics and Genomic Medicine, Uniklinik RWTH Aachen" OrgID="505336" OrganizationCategory="laboratory" OrgAbbreviation="IHG-UKRWTH" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The variant has not been reported in databases or in the literature. Truncating variants in POLR3B are known to be pathogenic. The variant was detected in a patient with clinical signs of HDL8 and a family history consistent with autosomal recessive inheritance; the patient also carries a second well-known pathogenic sequence variant in POLR3B. Based on this, the variant is considered to be likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POLR3B">
              <Name>RNA polymerase III subunit B</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_018082.5:c.1763del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614381" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10843957</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4004859" TraitType="Disease" MappingType="XRef" MappingValue="614381" MappingRef="OMIM">
        <MedGen CUI="C3280644" Name="Hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

